三变科技股份有限公司投资者关系活动记录表 编号：2025-001 投资者关系活动类 别 □特定对象调研 □分析师会议 □媒体采访 √业绩说明会 □新闻发布会 □路演活动 □现场参观 □其他 （请文字说明其他活动内容） 参与单位名称及人 员姓名 线上参与三变科技 2024 年度网上业绩说明会的投资者 时间 2025 年 05 月 12 日（星期一）下午 15:00-17:00 地点 "约调研"微信小程序 上市公司接待人员 姓名 董事长：谢伟世先生 独立董事：管宏斌先生 副总经理、财务总监兼董事会秘书：章日江先生 财务经理：何晓娇先生 投资者关系活动主 要内容介绍 1、问：公司定增项目发行进展？ 答：尊敬的投资者，您好！公司已于 2025 年 4 月 28 日 收到中国证监会出具的《关于同意三变科技股份有限公 司向特定对象发行股票注册的批复》，公司董事会将按 照有关法律法规和上述批复文件的要求及公司股东大 会的授权，在规定期限内办理本次向特定对象发行 A 股 股票的相关事宜，并及时履行信息披露义务。感谢您的 关注！ 2、问：请问公司营收净利润增长的原因？ 答：尊敬的投资者，您好！我公司积极应对行业市场的 变化，加 ...

编号：2025-002 | | □分析师会议 □特定对象调研 | | --- | --- | | 投资者关系活 | □媒体采访 □业绩说明会 | | 动类别 | □路演活动 □新闻发布会 | | | □现场参观 □反路演 | | | ☑其他（线上会议） 华泰资产管理有限公司、上海山楂树甄琢资产管理中心（有限合伙）、红杉资本股权投 | | | 管理有限公司、宏利基金管理有限公司、招商信诺资产管理有限公司、发展研究中心、 | | | 资管理(天津)有限公司、PINPOINT ASSET MANAGEMENT LIMITED、佛山市东盈投资 | | | 中信保诚基金管理有限公司、招银理财有限责任公司、新华基金管理股份有限公司、长 | | | 城财富资产管理股份有限公司、西南证券股份有限公司、浙商证券、上海混沌投资（集 | | | 团）有限公司、国寿安保基金管理有限公司、上海道合私募基金管理有限公司、博时基 | | 参与单位名称 | 金管理有限公司、汇添富基金管理股份有限公司、杭州萧山泽泉投资管理有限公司、建 | | | 信基金管理有限责任公司、中国人寿资产管理有限公司、平安基金管理有限公司、诺德 | | | 基金管 ...

证券代码：000591 证券简称：太阳能 中节能太阳能股份有限公司 投资者关系活动记录表 编号：2025-04 1 投 资 者 关 系 活 动 类 别 □特定对象调研 □分析师会议 □媒体采访 ☑业绩说明会 □新闻发布会 □路演活动 □现场参观 □其他 参 与 单 位 名 称 及 人 员姓名 2024 年年度业绩说明会参会人员 时间 2025 年 5 月 12 日 (周一) 下午 15：00~17：00 地点 网络互动 https://roadshow.cnstock.com/ 公 司 接 待 人员姓名 公司党委书记、董事长、总经理 张会学 独立董事 安连锁 副总经理、董事会秘书、总法律顾问 郭毅 总会计师 程欣 交 流 内 容 及 具 体 问 答记录 一、太阳能 2024 年年度业绩说明会采用网络远程方式进行， 对 2024 年年度业绩进行说明，并与投资者就其关心的问题进行交 流互动。总结互动内容要点如下： 1、公司对于市值管理有何规划？看公司公告了关于回购的计 划，何时开始实施？ 答： 公司高度重视市值管理工作，通过提升内在价值、优化信息 披露、加强投资者关系管理、坚持稳定的年度分红等多维度举 措，实现公 ...

Group 1: Company Performance and Challenges - The company faced a decline in gross margin and net profit due to factors such as national drug procurement policies, adjustments in medical insurance settlement methods, and rising raw material prices in 2024 [3] - In Q4 2024, the company reported a net loss of CNY 75.208 million, primarily due to decreased revenue and gross margin in the pharmaceutical distribution and medical services sectors, along with increased non-recurring losses [6] - The management acknowledged the concerns of investors regarding the company's performance and emphasized the importance of protecting investor rights [3] Group 2: Strategic Responses and Future Plans - The management is actively addressing challenges by enhancing medical service quality, optimizing long-term customer accounts in the pharmaceutical distribution sector, and promoting the development of traditional Chinese medicine [3] - The company plans to continue its efforts in market management and operational compliance to ensure long-term development and value creation for investors [3] - The company has implemented a share buyback and cash dividend strategy, distributing a total of CNY 171.2894 million in cash dividends in 2024, which accounted for 168.96% of the net profit attributable to shareholders [6] Group 3: Subsidiary Operations and Legal Matters - The subsidiary, Keke Pharmaceutical, is currently operating normally despite being under investigation, and the company will disclose any significant developments as required [4] - The management reassured investors that the ongoing legal matters would not adversely affect the subsidiary's operations or the company's overall performance [6]

Group 1: Financial Performance - The company achieved a total revenue of 3,834.16 million RMB in Q1 2025, representing a year-on-year growth of 10.36% [21] - The net profit attributable to shareholders reached 246.87 million RMB, with a year-on-year increase of 43.02% [21] - In 2024, the company's operating cash flow decreased by 29.10%, primarily due to increased cash payments for goods and services [22] Group 2: Market Expansion and Strategy - The company’s overseas business grew by 21.68% in 2024, driven by product category expansion and market penetration strategies [2] - Plans to expand into commercial appliances, personal care, pet appliances, and high-tech garden tools are underway to enhance product diversity [2] - The company is actively exploring new markets in Southeast Asia and Europe, with a focus on increasing sales in these regions [2][5] Group 3: Research and Development - The company has significantly increased its R&D investment to enhance product innovation capabilities and meet market demands [2][7] - Future R&D efforts will focus on smart home appliances and personalized product features [9] - The company aims to strengthen its core research areas and expand its product offerings in response to consumer needs [8] Group 4: Production and Supply Chain - The company established a manufacturing base in Indonesia, with an expected sales output of approximately 670 million RMB in 2024 [5][7] - The first phase of the Indonesian facility has been operational since late 2019, producing vacuum cleaners and other products [5] - A second phase is set to begin production in Q2 2025, with an additional investment of 50 million USD to expand capacity [5][7] Group 5: Brand and Market Positioning - The company employs a multi-brand strategy in the domestic market, with brands like Morphy Richards and Donlim positioned in the mid-to-high-end segment [4] - The acquisition of Morphy Richards has shown good profitability, contributing positively to the brand's market presence [8] - The company plans to enhance its marketing efforts and product launches to improve the performance of its domestic brands [9]

周大生珠宝股份有限公司 投资者关系活动记录表 投资者关系活动类别 □特定对象调研 □分析师会议 □媒体采访 □业绩说明会 □新闻发布会 □路演活动 □现场参观 √其他(电话会议) 参与单位名称 及人员姓名 共计 2 位投资者（排名不分先后）： 广发证券：包晗 人保资产：李爽 时 间 2025 年 5 月 12 日 地 点 线上 上市公司接待人员 姓名 证券事务代表：周晓达 投资者关系活动 主要内容介绍 一、 问答环节： 投资者主要就 2024 年年报及 2025 年一季报主要财务指标、品牌矩 阵、渠道扩张、金价波动、终端销售情况等问题进行了交流，可参阅前 次活动记录表之问答和已披露公告。 接待过程中，公司严格按照《信息披露管理制度》等规定，保证信 息披露的真实、准确、完整、及时、公平，没有出现未公开重大信息泄 露等情况。 附件清单（如有） 无 日期 2025 年 5 月 12 日 代码：002867 证券简称：周大生 编号：2025-018 ...

证券代码： 301232 证券简称：飞沃科技 湖南飞沃新能源科技股份有限公司投资者关系活动记录表 编号：2025-001 | 投资者关系活动 | □ 分析师会议 | □特定对象调研 | | --- | --- | --- | | 类别 | 媒体采访 √ 业绩说明会 | □ | | | 新闻发布会 □ 路演活动 | □ | | | 现场参观 | □ | | | 其他 （请文字说明其他活动内容） | □ | | 参与单位名称及 | 投资者网上提问 | | | 人员姓名 | | | | 时间 | 2025 年 5 月 12 日 (周一) 下午 15:30~17:00 | | | 地点 | 公司通过全景网"投资者关系互动平台"（https://ir.p5w.net） | | | | 采用网络远程的方式召开业绩说明会 | | | 上市公司接待人 | 1、董事长张友君 | | | 员姓名 | 2、董事会秘书刘志军 | | | | 3、总经理刘杰 | | | | 4、财务总监黎杰 | | | | 5、副总经理潘左熠 | | | | 6、独立董事夏劲松 | | | | 7、保荐代表人曹 冬 | | | | 投资者提出的问题及 ...

Group 1: Investor Relations Activity Overview - The company held an online earnings presentation for the fiscal year 2024 on May 9, 2025, from 15:00 to 17:00 [2] - The event was conducted on the "Value Online" platform, allowing for interactive communication with investors [2] Group 2: Key Clientele and Market Position - Major clients include China National Railway Group, China CRRC, and China Railway Construction, with no current plans for additional social shareholder investments [3] - The company aims to enhance its competitive edge by increasing R&D efforts and adapting products to meet market demands [3] Group 3: Product Development and Innovation - The railway platform adaptive safety door system has passed expert review and is in preparation for market promotion [4] - The company is focusing on integrating 5G and AI technologies into rail transit, conducting market research to align with user needs [4] Group 4: Quality Control and Management - The company emphasizes scientific design and management in its quality control processes, enhancing supplier management and product testing [4] - A comprehensive quality management system based on GB/T9001-2016 is in place, with regular updates and certifications [6] Group 5: Customer Structure Optimization - The company plans to continue focusing on existing high-quality clients while actively seeking new business opportunities [5] - Collaborations with universities like Beijing Jiaotong University and Southwest Jiaotong University are established to foster innovation and talent development [6]

| 不 入住或选择相应方案为止。在这一阶段，AI Agent | | --- | | 只是公司精准获客的高效助手，更是帮助长者和家属 | | 理解、评估并顺利过渡到新生活模式的引导者。 | |  日 常 生 活 与 社 交 娱 乐 （ Daily Living & Social | | Engagement）：在长者加入养老社区或选择居家养老 | | 方案后，为其日常生活、兴趣培养和社交拓展提供全 | | 面支持。 | |  健康与安全保障（Health & Safety Management）：从 | | 日常健康监测到应急处理，为长者的身体和心理健康 | | 提供持续支持与保障。 | | 发布会具体安排敬请留意公司官网、微信公众号（国脉科 | | 技 GMTECH、国脉大学养老）及视频号（国脉大学养老） | | 预告信息。 | | 2、公司的 AI Agent 有何不同？ | | 答：目前市面上的智能体大多都在强调"通用型"，目标 | | 是能适应大部分场景，但我们认为 AI agent 并非"万能工 | | 具"，在行业的深度知识不足的情况下，通用型智能体很难 | | 提升用户体验。因此，结合公司在 ...

Group 1: Company Overview and Operations - Guizhou Chuanheng Chemical Co., Ltd. focuses on the production of food-grade purified phosphoric acid, which is sold through market-oriented sales channels [2]. - The company is currently enhancing production capacity for its key project in Guangxi, with a target to achieve full production soon [4]. Group 2: Financial Performance and Profitability - The company aims to improve net profit through several measures, including optimizing phosphate ore mining and production operations [4]. - Specific strategies to mitigate risks from raw material price fluctuations and industry competition include ongoing R&D investments and cost reduction initiatives [4]. Group 3: Market Position and Competitive Advantage - The company emphasizes its competitive advantages compared to peers like Yuntianhua and Xingfa Group, although specific details were not disclosed [4]. - The pricing strategy for phosphate chemical products is aligned with market trends, with fluctuations influenced by various factors [4]. Group 4: Future Plans and Projections - The company has not disclosed specific quantitative targets for net profit for the upcoming years, citing uncertainties in macroeconomic conditions and market demand [5]. - Future plans may include expanding into new energy sectors, although details remain under regulatory compliance [4].